RE:RE:Phase 1 buildout FV Pharma owns approx 12% of Cannara. the reasonning behind this was to heavily speed up the application process for cultivation licence for growth, a very strategic move that will cut wait time heavily. FV pharma is already licenced, so the Cannara building is considered an extention of their cultivation licence, therefore only the building needs to be approved by health canada in order to start growing. again, very strategic agreement put in to place that elimintaed the lengthy wait process for licencing, and a move that will make investors realize that this company is no joke. in the mean time that the growth process has begun, you can expect cannara to have already applied for a licence of their own. hope this helps